Drug intelligence / Profile preview

Sichong tablet

Development stage: Unknown
Lead developer: Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Sichong tablet is a traditional Chinese medicine formulation investigated for the treatment of deep venous thrombosis (DVT) of the lower extremity. It is being studied in clinical trials, particularly in chronic DVT patients, but detailed information about its composition, mechanism of action, or specific active ingredients has not been provided in available sources. The drug appears to be used as an adjunct or alternative to standard anticoagulant therapy and is evaluated for its effects on coagulation parameters and quality of life measures in DVT patients[1].

Brand names: Sichong tablet
Other names: Sichong

Beyond the preview

Go deeper on Sichong tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sichong tablet.

Explore the full profile